What Alliance for Artificial Intelligence in Healthcare does

The Alliance for Artificial Intelligence in Healthcare (AAIH) is a 501(c)(4) non-profit advocacy coalition founded in January 2019 and headquartered in San Diego, California, with additional presence in Washington D.C. and the European Union. It convenes more than 50 member organizations spanning pharmaceutical companies (Roche, Bayer, GSK, Janssen), AI-native biotechs (Insilico Medicine, Recursion, Cyclica, Envisagenics), medical technology and diagnostics vendors (GE Healthcare), academic and research institutions (University of Pittsburgh, The Buck Institute for Research on Aging), and major technology platforms (Amazon Web Services, Google, Microsoft). Its core function is to develop, socialize, and advocate for responsible, ethical, and reasonable standards, regulatory frameworks, and policy positions for AI in healthcare, operating through standing Regulatory Affairs and Data Working Groups that engage directly with the FDA, EMA, Health Canada, and NIST.

AAIH's substantive outputs are publications, working-group frameworks, and convenings rather than commercial products. The portfolio includes the 'AI in Health Sciences Playbook' for C-suite leaders, white papers on unified patient records and AI lifecycle governance, webinars, and industry conference programming at BIO International Convention, BiotechX, AI in Health Conference, and JPM Healthcare Week. In April 2024, AAIH formalized a collaboration with NIST through the AI Safety Institute Consortium to develop science-based AI measurement and policy guidelines, extending its regulatory engagement beyond healthcare-specific agencies into broader AI safety policy. The organization is administratively powered by the Connect Foundation, with leadership drawn from member companies (e.g., Chair Mustaqhusain Kazi of Roche/Genentech) and a small central staff led by Executive Director Elaine Hamm.

AAIH's revenue model is membership-dues based and recurring. There are no individual memberships; only companies and organizations developing, investing in, or applying AI platforms and products for healthcare may join, contingent on signing a shared member code of conduct. Specific dues are not publicly disclosed. The organization has 1-10 employees, generating no product revenue, and is structured without external investors or parent-company ownership, governed instead by a Board of Directors and Executive Officers elected from member organizations.

Name

Alliance for Artificial Intelligence in Healthcare

Legal name

Alliance for Artificial Intelligence in Healthcare

Website

https://theaaih.org

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

AAIH is a 501(c)(4) non-profit advocacy coalition of 50+ healthcare and technology organizations that develops standards and policy frameworks for responsible AI in healthcare through working groups engaging the FDA, EMA, Health Canada, and NIST.

Ownership category

akta.pro rank

Product category

Healthcare AI Advocacy and Policy

NAICS

Business Associations (813910), Professional Organizations (81392)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

akta.pro secondary industry

Audit, Explainability & Accountability Tooling (traceability, reporting) (HDAAAKAL)

Keywords

• Healthcare AI advocacy
• AI policy standards
• Regulatory working groups
• Healthcare coalition membership
• AI industry publications

Headquarters

HQ city

Baltimore

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Dues: AAIH operates as a coalition supported by member dues from pharmaceutical companies, technology developers, research organizations, and other healthcare AI stakeholders. Membership requires signing a code of conduct and committing to industry expectations for responsible AI development.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

AAIH is a membership-based advocacy coalition that convenes technology developers, pharmaceutical companies, research organizations, and government stakeholders to drive responsible AI adoption in healthcare. Its core deliverable is industry representation to regulators (FDA, EMA, Health Canada, NIST) along with standing working groups, white papers, webinars, and publications that shape AI policy, regulatory frameworks, and data accessibility standards across biomedical discovery, clinical research, and medical device/diagnostics applications.

Product overview

The Alliance for Artificial Intelligence in Healthcare (AAIH) is a global advocacy organization (501(c)(4) non-profit) dedicated to the discovery, development, and delivery of better solutions to improve patient lives through AI. Rather than offering a commercial product, AAIH serves as an industry coalition providing whitepapers, webinars, industry events, and committee-driven advocacy work. Key offerings include the Regulatory Affairs Working Group addressing FDA/EMA frameworks, the Data Working Group focusing on real-world data accessibility, and various publications including the AI Playbook for Healthcare. The organization convenes stakeholders across pharma, diagnostics, medtech, and technology sectors to establish responsible, ethical, and reasonable standards for AI in healthcare.

Differentiator

Problem solved

Functional benefit

Products and services

• AAIH Advocacy and Industry Coordination Coalition-level advocacy and policy engagement for healthcare AI stakeholders, including unified industry representation to FDA, EMA, Health Canada, and NIST, and code-of-conduct-based membership for qualifying companies and organizations.
• Regulatory Affairs Working Group Standing member working group that develops frameworks for AI/ML regulatory approaches and engages with FDA's Digital Health Center of Excellence, the Software as a Medical Device (SaMD) framework, Good Machine Learning Practice (GMLP), and EMA's Digital Health Technology integrated consultation platform.
• Data Working Group Standing member working group that addresses data accessibility challenges through mapping data sources, engaging government entities, developing privacy policies, and operating a real-world data registry and clearinghouse for quality data across government, industry, and academia.
• AI in Health Sciences Playbook Strategic playbook for C-suite leaders across Pharma, Diagnostics, and Medtech outlining how industry pioneers use AI to drive measurable value at scale.
• Webinars and Presentations Program Series of webinars and presentations featuring expert discussions on AI in drug development, regulatory updates, and healthcare data topics available through the AAIH publications and events channel.

Named customers12 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

20 partnerships are on record, tiered core.

• National Institute of Standards and Technology (NIST)coreStrategic or Co-development Partner · 17 April 2024AAIH is collaborating with NIST in the Artificial Intelligence Safety Institute Consortium to develop science-based and empirically backed guidelines and standards for AI measurement and policy. This collaboration aims to lay the foundation for AI safety across the world and help the U.S. address capabilities of next generation AI models with appropriate risk management strategies.
• GooglecoreStrategic or Co-development Partner · 25 May 2021Google joined AAIH as a member in 2021, representing technology companies participating in healthcare AI.
• Roche (additional membership)coreStrategic or Co-development Partner · 25 May 2021Roche joined as member in 2021, expanding pharmaceutical representation in AAIH alongside Genentech operations.
• RochecoreStrategic or Co-development Partner · 1 January 2019Roche is a founding member of AAIH and has held leadership positions including Board Chair. Roche represents the pharmaceutical and healthcare AI innovation sector within the coalition, contributing to regulatory affairs and policy development initiatives.
• BayercoreStrategic or Co-development Partner · 1 January 2019Bayer is a founding member of AAIH, representing the pharmaceutical sector in the coalition focused on advancing responsible AI adoption in healthcare.
• Insilico MedicinecoreStrategic or Co-development Partner · 1 January 2019Insilico Medicine is a founding member company specializing in AI-driven drug discovery. CEO Alex Zhavoronkov serves on the AAIH Board of Directors.
• RecursioncoreStrategic or Co-development Partner · 1 January 2019Recursion is a founding member company focused on AI-enabled drug discovery. The company has held leadership positions including past chairperson of the board and continues to actively participate in AAIH initiatives.
• CyclicacoreStrategic or Co-development Partner · 1 January 2019Cyclica is a founding member company providing AI-driven drug discovery platforms. CEO Naheed Kurji served as AAIH Board Chair for 2022.
• EnvisagenicscoreStrategic or Co-development Partner · 1 January 2019Envisagenics is a founding member specializing in RNA splicing analytics AI. CEO Maria Luisa Pineda serves as AAIH Secretary.
• OWKINcoreStrategic or Co-development Partner · 1 January 2019OWKIN is a member company focused on federated learning and AI in healthcare. SVP Joseph Lehár represents OWKIN on the AAIH Board.
• GenialiscoreStrategic or Co-development Partner · 1 January 2019Genialis is a member company and board participant. CEO Rafael Rosengarten serves as AAIH Board Director and co-founder.
• GE HealthcarecoreStrategic or Co-development Partner · 1 January 2019GE Healthcare is a founding member representing the medical technology and imaging sector in AAIH.
• GSKcoreStrategic or Co-development Partner · 1 January 2019GSK is a founding member representing the pharmaceutical sector in the coalition.
• JanssencoreStrategic or Co-development Partner · 1 January 2019Janssen (Johnson & Johnson) is a founding member. Najat Khan serves as Chief Data Science Officer and Global Head of Janssen R&D Strategy on the AAIH Executive Committee.
• University of PittsburghcoreStrategic or Co-development Partner · 1 January 2019University of Pittsburgh is a founding member representing academic research institutions in AAIH.
• The Buck Institute for Research on AgingcoreStrategic or Co-development Partner · 1 January 2019The Buck Institute is a founding member representing research organizations focused on aging and longevity research in the coalition.
• Amazon Web ServicescoreStrategic or Co-development Partner · 1 January 2019Amazon Web Services is a founding member representing cloud infrastructure and technology providers in AAIH.
• U.S. Food & Drug Administration (FDA)coreStrategic or Co-development PartnerAAIH works with FDA through engagement on regulatory guidance for AI in healthcare, including Good Machine Learning Practice (GMLP) and Software as a Medical Device (SaMD) frameworks.
• European Medicines Agency (EMA)coreStrategic or Co-development PartnerAAIH engages with EMA on Digital Health Technology integrated consultation platform and European regulatory frameworks for AI in healthcare.
• Health CanadacoreStrategic or Co-development PartnerAAIH collaborates with Health Canada on regulatory affairs related to AI in healthcare.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Medical Device Innovation Consortium (MDIC): MDIC is a public-private partnership working on medical device regulatory science, including AI/ML-enabled devices. Comparable in convening industry, government, and academia to advance regulatory frameworks — directly relevant to AAIH's medical device segment work.
• Health Innovation Alliance: A coalition advocating for technology-enabled healthcare innovation, including AI policy. Operates in adjacent policy space to AAIH with a slightly broader health-tech (rather than healthcare-AI) framing.

Broad incumbents

• Biotechnology Innovation Organization (BIO): BIO is the largest U.S. trade association for the biotechnology industry, including AI-driven drug discovery members. AAIH is narrower in focus (AI-specific) but competes for member mindshare and regulatory influence within BIO's portfolio.
• AdvaMed: AdvaMed is the leading medical technology industry association, including AI/ML-enabled medical device members. Overlaps with AAIH on regulatory frameworks for AI in medical devices (SaMD, GMLP) but serves the broader medtech industry.
• PhRMA: PhRMA is the primary U.S. pharmaceutical industry trade association with active engagement on AI/ML policy. Comparable as an advocacy coalition representing pharma on regulatory matters, but far broader in scope and resources than AAIH.

Direct peers

• Coalition for Health AI (CHAI): CHAI is a healthcare AI coalition focused on responsible AI adoption standards and best practices, working directly with FDA and other regulators. It is the most directly comparable peer to AAIH in mission, structure (multi-stakeholder coalition), and regulatory engagement focus.
• Digital Medicine Society (DiMe): DiMe is a non-profit professional society driving the adoption of digital medicine, including AI-enabled clinical tools. Comparable to AAIH in operating as a member-supported community that convenes stakeholders, publishes frameworks, and engages regulators on digital health.

Regional players

• American Medical Informatics Association (AMIA): AMIA is a U.S.-focused professional association for informatics in healthcare, with growing AI policy activity. Comparable as a membership organization publishing standards and engaging regulators, but academic/professional rather than industry-led.
• European Federation of Pharmaceutical Industries and Associations (EFPIA): EFPIA is the European pharmaceutical industry association engaging with EMA on AI and digital health frameworks. Comparable as an industry coalition on healthcare AI regulation, but primarily EU-focused and broader in scope.

Others

• Health Level Seven International (HL7): HL7 is a global standards development organization for health data interoperability, including AI-relevant data exchange standards. Comparable in producing technical standards that shape healthcare AI deployment, but operating as a formal SDO rather than an industry advocacy coalition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/theaaih
• LinkedInlinkedin.com/company/theaaih

Revenue estimate

Valuation estimate

Number of profiles

Profiles23 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alliance for Artificial Intelligence in Healthcare